ClinicalTrials.gg
Not yet recruitingNCT07690592Updated Jul 8, 2026

A Single-arm Pilot Feasibility Trial of Healthy Pride

An interventional study of lifestyle intervention in Obesity & Overweight, sponsored by University of Connecticut. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-07-08.

Sponsored by University of Connecticut · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This is a one-arm pilot trial of a 12-week digitally-delivered asynchronous lifestyle intervention designed for gay men and lesbian women. After the program, we will gather feedback on the acceptability of the program and unique barriers to weight loss experienced by this population, including weight stigma.

Read the detailed description

The purpose of the proposed work is to advance our understanding of the unique barriers to weight management experienced by sexual minority men and women with obesity to inform the development of a lifestyle intervention that is tailored to their needs. We will recruit 40 participants with obesity, 20 who identify as lesbian women and 20 who identify as gay men. Once recruited, we will send participants a digital scale to verify their weight at baseline and at 12 weeks. At baseline, we will ask participants to complete a survey to assess their needs and preferences for a digital lifestyle intervention. We will use that information to make modifications to our digital lifestyle intervention which was originally based on the Diabetes Prevention Program (DPP). They will then be enrolled in a 12-week digital lifestyle intervention to be delivered asynchronously via a private Facebook group where they can participate confidentially. During the intervention they will be asked to use a commercial calorie tracking app to track their dietary intake and exercise and meet a daily calorie goal that will produce 1-2 pound weight loss per week. They will also be asked to use the scale we provided to weigh themselves at least once per week. Each week, they will be given a weekly diet goal to help them achieve a heart healthy calorie controlled diet and a weekly exercise goal to help them gradually reach 150 minutes of moderate intensity physical activity per week and 3 days of strength training exercises targeting at least 3 muscle groups. In the Facebook group, one module of the DPP will be covered each week via 14 posts that will occur twice daily from the study dietitian account. Posts will be conversation starters designed to engage participants in the DPP content. Participants will also be encouraged to post updates in the group and to support each other via reactions and replies. After the 12-week intervention we will examine retention, engagement, acceptability of the intervention, and group cohesion. We will also collect qualitative data on participants' perspectives of strengths and weaknesses of the program and ways to improve it.

02

Conditions studied

  • Obesity & Overweight

Keywords

  • obesity
  • weight loss
  • weight management
  • healthy diet
  • exercise
  • LGBTQ
  • sexual minority
  • gay
  • lesbian
03

In context

Obesity

11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.

This study's planned enrollment of 40 is below the median of 67 across 9,006 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

University of Connecticut is the lead sponsor of 135 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 27-45 kg/m2
  • Gay male, and lesbian female
  • Wi-Fi connectivity at home
  • Has a Facebook account and is willing to log into it daily during the study
  • Has a smartphone
  • Able to participate in the study in English
  • Interested in losing weight
  • Lives in United States

Exclusion criteria

Exclusion Criteria:

  • Pregnant/lactating or plans to become pregnant during study period
  • Reports having bipolar disorder, substance abuse, psychosis, an eating disorder, or severe depression
  • Had bariatric surgery or plans to have surgery during the study
  • Currently taking medication affecting weight (e.g., neuroleptics/antipsychotics, mood stabilizers, weight loss medication, or tricyclic antidepressants)
  • Has lost ≥5% of weight in past 6 months
  • Is participating or intends to participate in another weight loss program during the study
  • Chronic pain that interferes with the ability to exercise
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Unable to make dietary changes or increase physical activity due to a medical condition(s)
  • Unable to walk ¼ mile unaided without stopping
  • Unable to walk ¼ without experiencing chest pain or dizziness
  • Had a previous myocardial infarction/heart attack
  • Has a known coronary artery disease (not including hypertension)
  • Has chronic kidney disease
  • Has a heart valve abnormality
  • Has a heart arrhythmia
  • Currently smokes or vapes nicotine
  • Meets criteria for severe depression on the PHQ-8 (score of >19)
  • Participated in previous weight loss studies under the PI
  • If UConn employee/student, has concerns about being in a Facebook group/meeting with other UConn faculty, staff, and students
  • Had major surgery in past 6 months and have not been cleared by their doctor to resume physical activity and diet changes
  • Plans to have major surgery during the study period
  • Prisoner
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    lifestyle intervention

    12-week lifestyle intervention

    Behavioral: lifestyle intervention

Interventions

  • Behaviorallifestyle intervention

    12-week digitally-delivered asynchronous lifestyle intervention

06

What researchers measure

Primary outcomes

  1. Retention

    The percent of participants who provided weight data at 12 weeks

    Time frame: 12 weeks

  2. Engagement

    Total number of engagements during the intervention (reactions, replies, poll votes, and posts)

    Time frame: 12 weeks

  3. Intervention satisfaction

    a 0-6 Likert scale rating of how satisfied they were with the weight loss program overall

    Time frame: 12 weeks

Secondary outcomes

  1. Inclusivity

    the sum of 3 likert scale items (0-6) on how welcoming the program was to gay people, how adequately tailored it was to gay people, and how included the group made them feel

    Time frame: 12 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — De-identified data and data dictionaries

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Jan 2027, 6 months later.

Of 3,680 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 6 months is below that.

Counting every sponsor, half of 3,843 studies reached it within 22 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 1, 2026
First posted
Jul 8, 2026
StartEst.
Jul 15, 2026
Primary completionEst.
Jan 30, 2027
CompletionEst.
Jan 30, 2027
Last update
Jul 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07690592
Responsible party
Sherry Pagoto (Professor, University of Connecticut) — Principal investigator
First posted
Jul 8, 2026
Start date
Jul 15, 2026 (estimated)
Primary completion
Jan 30, 2027 (estimated)
Completion
Jan 30, 2027 (estimated)
Last update
Jul 8, 2026

Study contacts

Denise Fernandes
Contact
denise.fernandes@uconn.edu
860-515-8186
Sherry Pagoto, PhD
Contact
sherry.pagoto@uconn.edu
Sherry Pagoto, PhD
principal investigator · University of Connecticut

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion